EODData

MEMBERSHIP REGISTER LOG IN

OTCBB, LZAGF: Lonza Group Ag

29 Jan 2026
LAST:

730.2

CHANGE:
 14.03		OPEN:
685.8		HIGH:
730.2		ASK:
0.0		VOLUME:
1.1K
CHG(%):
1.96		PREV:
716.2		LOW:
685.7		BID:
0.0		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
29 Jan 26685.8730.2685.7730.21.1K
28 Jan 26719.2753.3707.2716.2100
27 Jan 26723.5743.4723.0743.4300
26 Jan 26719.7723.8681.9712.21.0K
23 Jan 26718.6719.1675.3715.1300
22 Jan 26722.5722.5698.3700.430.1K
21 Jan 26705.6717.6684.8717.6100
20 Jan 26707.7710.1684.3709.6500
16 Jan 26697.4706.9693.2706.9300
15 Jan 26721.7721.7701.5721.5100

PROFILE

Name:Lonza Group Ag
About:Lonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Biologics; Small Molecules; Cell & Gene; and Capsules & Health Ingredients segments. The Biologics segment engages in the contract development and manufacturing of biopharmaceuticals for clinical and commercial manufacturing needs throughout the product lifecycle, including drug substance and drug product manufacturing. Its Small Molecules segment provides integrated development and manufacturing services for small molecule drug substances and their intermediates. This segment also supports customers across aspects of design, development, and manufacturing, such as particle engineering and drug product packaging. The Cell & Gene segment develops technologies and platforms that industrialize the manufacturing processes and production of cell and gene therapies; offers contract development and manufacturing services, and regulatory support for a range of allogeneic and autologous cell therapies, and exosome-based therapies, as well as viral vector gene therapies. This segment also provides Cocoon platform, a closed automated system for patient-scale cell therapy manufacturing; and specialty raw materials and enabling technology solutions in cell and gene therapy, injectable drugs, vaccines, and bio-manufacturing markets. Its Capsules & Health Ingredients segment offers capsules, dosage form solutions, and health ingredients for pharmaceutical and nutraceutical customers. Lonza Group AG was incorporated in 1897 and is headquartered in Basel, Switzerland.
Sector:Healthcare
Address:Muenchensteinerstrasse 38, Basel, Switzerland, 4002
Website:https://www.lonza.com
CIK:0001446711
FIGI:BBG000P5J2P8

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:53.64 
Forward P/E:28.09 
Price to Sales:6.92 
Price to Book:4.45 
DivYield:0.01 
Div/Share:4.00 
Revenue:7.093B 
EBITDA:1.945B 
Shares:70.15M 
Market Cap:51.223B 

TECHNICAL INDICATORS

MA5:723.430.9%
MA10:717.311.8%
MA20:706.643.3%
MA50:685.996.4%
MA100:686.926.3%
MA200:693.465.3%
STO9:56.38
STO14:56.70
RSI14:59.22
WPR14:-30.28
MTM14:30.24
ROC14:0.04 
ATR:31.17 
Week High:753.323.2%
Week Low:675.318.1%
Month High:753.323.2%
Month Low:649.075.3%
Year High:755.963.5%
Year Low:560.5130.3%